Correction: Ritter et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498

Ritter, Emese; Hohl, Kitti; Kereskai, László; Kemény, Ágnes; Hargitai, Dóra; Szombati, Veronika; Perkecz, Anikó; Pakai, Eszter; Garami, Andras; Zsembery, Ákos; Helyes, Zsuzsanna; Csekő, Kata

doi:10.3390/biomedicines13102384

Open AccessCorrection

Correction: Ritter et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498

by

Emese Ritter

¹,

Kitti Hohl

^1,†,

László Kereskai

²,

Ágnes Kemény

^1,‡

,

Dóra Hargitai

³,

Veronika Szombati

¹,

Anikó Perkecz

¹,

Eszter Pakai

⁴,

Andras Garami

⁴

,

Ákos Zsembery

⁵,

Zsuzsanna Helyes

^1,6,7,8,§ and

Kata Csekő

^1,6,*,§

¹

Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary

²

Department of Pathology, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary

³

Department of Pathology, Forensic and Insurance Medicine, Faculty of Medicine, Semmelweis University, Üllői út 93, H-1091 Budapest, Hungary

⁴

Department of Thermophysiology, Institute for Translational Medicine, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary

⁵

Department of Oral Biology, Faculty of Dentistry, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary

⁶

National Laboratory for Drug Research and Development, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary

⁷

HUN-REN-PTE Chronic Pain Research Group, H-7624 Pécs, Hungary

⁸

PharmInVivo Hungary Ltd., Szondy György u 10, H-7629 Pécs, Hungary

^*

Author to whom correspondence should be addressed.

^†

Current address: Department of Public Dental Health, Faculty of Dentistry, Semmelweis University, Szentkirályi u. 40, H-1088 Budapest, Hungary.

^‡

Current address: Department of Physiology and Biochemistry, University of Veterinary Medicine, István u. 2, H-1078 Budapest, Hungary.

^§

These authors contributed equally to this work.

Biomedicines 2025, 13(10), 2384; https://doi.org/10.3390/biomedicines13102384

Submission received: 5 September 2025 / Accepted: 8 September 2025 / Published: 28 September 2025

(This article belongs to the Section Molecular and Translational Medicine)

Download Versions Notes

Error in Table

In the original publication [1], there was a mistake in Table 1 as published. As Ref. 14 has been retracted, it was deleted from the paper along with the related main text. Therefore, the third row of Table 1 was deleted. The corrected Table 1 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

As Ref. 14 has been retracted, it was deleted from the original paper [1]. With this correction, the order of some references has been adjusted accordingly.

References

Ritter, E.; Hohl, K.; Kereskai, L.; Kemény, Á.; Hargitai, D.; Szombati, V.; Perkecz, A.; Pakai, E.; Garami, A.; Zsembery, Á.; et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498. [Google Scholar] [CrossRef]

Table 1. Different LPS ALI model paradigms in the literature. (n.r.: not reported; n.u.: not used; i.p.: intraperitoneal; M: male; F: female; DEXA: dexamethasone).

LPS Dose	LPS Route of Admin	LPS Serotype	Strain	Sex	Endpoint	Anti-Inflammatory Drug Testing	Reference Compound	Reference
0.5 mg/kg (10 µg)	intratracheal	n.r.	C57BL/6J	M	24 h	Panaxydol	n.u.	Li et al., 2021 [13]
0.5 mg/kg (10 µg)	intranasal	n.r.	BALB/c	M	day 7	Fuzhengjiedu formula	DEXA (1.5 mg/kg)	Lu et al., 2024 [14]
1 mg/kg	intratracheal	O111:B4	C57BL/6J, STAT6^flox/flox	n.r.	24 h	n.u.	n.u.	Yang et al., 2022 [15]
		O111:B4	MMP3^+/+, MMP3^−/−	M, F	18 h	n.u.	n.u.	Puntorieri et al., 2016 [16]
		O111:B4	n.r.	M, F	6 h	n.u.	n.u.	Speyer et al., 2005 [17]
		n.r.	C57BL/6J	n.r.	16 h	n.u.	n.u.	Kovacs-Kasa et al., 2021 [18]
	intranasal	O55:B5	BALB/c	M	24 h	B7H3	n.u.	Li et al., 2016 [19]
2 mg/kg	intratracheal	O55:B5	C57BL/6J	M	6, 12, 24, 48, 72 h	erlotinib	n.u.	Tao et al., 2019 [20]
2.5 mg/kg (50 µg)	aspiration	O111:B4	C57BL/6J	M, F	6 h	n.u.	n.u.	Card et al., 2006 [21]
2.5 mg/kg (50 µg)	inhalation	O55:B5	ICR	M	day 14	Xuanfei Baidu formula	DEXA (0.4 mg/kg)	Li Z et al., 2023 [22]
3 mg/kg	intratracheal	O111:B4	C57BL/6J, Trem2^−/−	M	48 h	rhein, NFATc1 inhibitor	n.u.	Li X et al., 2023 [23]
3 mg/kg	intratracheal	O55:B5	C57BL/6J	M, F	day 3, 7	n.u.	n.u.	Mock et al., 2023 [24]
75 µg	intratracheal	O111:B4	C57BL/6J	M	24 h, day 4, 7, 28	n.u.	n.u.	Tsikis et al., 2022 [25]
4 mg/kg	n.r.	n.r.	C57BL/6J	M	day 7	Xuanfei Baidu Decoction	DEXA (5 mg/kg)	Wang et al., 2022 [26]
5 mg/kg	intratracheal	O111:B4	C57BL/6J	M	12, 24 h	FGF1	n.u.	Dhlamini et al., 2022 [27]
		O111:B4	C57BL/6J	M	12 h	PTUPB	n.u.	Yang et al., 2020 [28]
		O111:B4	C57BL/6J	n.r.	48 h	fluorofenidone	n.u.	Lv et al., 2021 [29]
		O55:B5	CC10-rtTA/(tetO)7-Cre/cGAS^flox/flox	n.r.	24 h	n.u.	n.u.	Jin et al., 2023 [30]
		O55:B5	ICR	M	72 h	Forsythiaside A	DEXA (5 mg/kg)	Wang et al., 2024 [31]
		n.r.	C57BL/6J	n.r.	24 h	valsartan	n.u.	Zhou et al., 2024 [32]
	intranasal	O111:B4	C57BL/6J, GP6^−/−	M	4 h	JAQ1	n.u.	Burkard et al., 2023 [33]
	intranasal	n.r.	C57BL/6J	M	24 h	PEP-sNASP peptide	n.u.	Wu et al., 2022 [34]
	i.p. injection	O111:B4	C57BL/6J	M	48 h	n.u.	n.u.	Chen et al., 2023 [35]
	i.p. injection	n.r.	C57BL/6J	M	24 h	orexin-A	n.u.	Nie et al., 2023 [36]
	n.r.	n.r.	C57BL/6J, MD2^−/−, TLR4^−/−	M	6, 24 h	licochalcone A	n.u.	Zhu et al., 2023 [37]
180 µg; 3 × 60 µg	intranasal	n.r.	Bcl-2-(1/2)	M, F	day 1, 2, 3, 4	n.u.	n.u.	Tesfaigzi et al., 2001 [38]
15 mg/kg	Caudal vein	O55:B5	C57BL/6J, Nrf2^−/−	M	12 h	n.u.	n.u.	Ma et al., 2023 [39]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Ritter, E.; Hohl, K.; Kereskai, L.; Kemény, Á.; Hargitai, D.; Szombati, V.; Perkecz, A.; Pakai, E.; Garami, A.; Zsembery, Á.; et al. Correction: Ritter et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498. Biomedicines 2025, 13, 2384. https://doi.org/10.3390/biomedicines13102384

AMA Style

Ritter E, Hohl K, Kereskai L, Kemény Á, Hargitai D, Szombati V, Perkecz A, Pakai E, Garami A, Zsembery Á, et al. Correction: Ritter et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498. Biomedicines. 2025; 13(10):2384. https://doi.org/10.3390/biomedicines13102384

Chicago/Turabian Style

Ritter, Emese, Kitti Hohl, László Kereskai, Ágnes Kemény, Dóra Hargitai, Veronika Szombati, Anikó Perkecz, Eszter Pakai, Andras Garami, Ákos Zsembery, and et al. 2025. "Correction: Ritter et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498" Biomedicines 13, no. 10: 2384. https://doi.org/10.3390/biomedicines13102384

APA Style

Ritter, E., Hohl, K., Kereskai, L., Kemény, Á., Hargitai, D., Szombati, V., Perkecz, A., Pakai, E., Garami, A., Zsembery, Á., Helyes, Z., & Csekő, K. (2025). Correction: Ritter et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498. Biomedicines, 13(10), 2384. https://doi.org/10.3390/biomedicines13102384

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Ritter et al. Optimization, Characterization and Pharmacological Validation of the Endotoxin-Induced Acute Pneumonitis Mouse Model. Biomedicines 2025, 13, 1498

Error in Table

Reference

References

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI